68 Cases Of Pulmonary Interstitial Fibrosis Syndrome Of Traditional Chinese Medicine Clinical Research

Objective:Analyzed and summarized the relationship between the general and traditional Chinese medicine syndrome patients with interstitial pulmonary fibrosis and other factors to explore the pulmonary fibrosis TCM Clinical Syndromes, the clinical differential diagnosis of the disease treatment is to provide relevant theoretical basis.Method:This issue through a survey questionnaire to record the general information of the68cases of patients with pulmonary fibrosis, the incidence, diagnosis and treatment of, with the four diagnostic information. Frequency statistics, analyze and summarize the TCM syndromes law, as well as glucocorticoid therapy, combined autoimmune disease and other factors and syndromes changing relationship of the relevant factors.Result:①68cases of pulmonary fibrosis in patients with an average age of63.89±1.52years old,61-70age group, incidence of up to71years-80year age group, constitute a significant difference (P<0.05) among age groups. Female age at onset is earlier than men. Their survival rate increased with age decline.②Previous smoking history and dust, harmful gases and smoke, history of exposure to important risk factor for pulmonary fibrosis patients.③68cases of pulmonary fibrosis in patients with previous merger respiratory diseases and autoimmune diseases are more common.④The onset of pulmonary fibrosis most of the air smell stimulate the incentives caused by a small number of patients with no obvious incentive.⑤Interstitial lung fibrosis dialectical main disease location change in the lung, chief spleen, kidney, heart, liver, spleen and kidney involvement is more common.⑥Pulmonary fibrosis of the case of false is the syndrome of intermingled deficiency and excess, lung yang is more common and more complicated with kidney yang; standard real dry phlegm, blood stasis is more common. The only disease in the lung to merge the excess syndromes are dry phlegm blood stasis、cold phlegm. But disease involving the spleen, kidney, then the multi-merge phlegm, dampness and water metabolism disorders are common. There are Qiyinliangxu course of late, Yinyangliangxu and other evidence. Then the disease location may involve the heart, liver。⑦This subject in the syndromes and duration of the correlation between poor acceptance syndromes was not very significant difference between the glucocorticoid therapy group and non-glucocorticoid therapy group (P>0.05). Patients with autoimmune disease who permit the merger climate more yin-based rare phlegm, dampness of the card. ⑧Higher than non-smoking patients with a history of smoking patients with a history of the proportion of blood stasis.Conclusion:Pulmonary fibrosis men and women the incidence is no different from the age of onset more than50years of age, female patients were younger than men. Previous history of smoking and exposure to dust, harmful gases and smoke, the risk of pulmonary fibrosis is an important factor. Previous history of chronic respiratory diseases, and autoimmune history of interstitial lung fibrosis, a history of an important association. Survival rate decreased with the prolongation of the duration of pulmonary fibrosis.TCM syndromes:Interstitial pulmonary fibrosis in patients with disease located in the lung, which is more common than spleen and kidney, heart or liver. The pathogenesis of pulmonary fibrosis is the syndrome of intermingled deficiency and excess, lung and kidney yang deficiency more common, lung and spleen and kidney yang, merging the excess syndromes of dry phlegm, blood stasis is more common. The only disease in the lung to merge the excess syndromes is more common to dry phlegm, blood stasis, Han Tan, disease phase and the spleen and kidney deficiency, phlegm, dampness such as water gather syndrome are more common. Pulmonary fibrosis combined patients with autoimmune disease Yin Deficiency is more common, and phlegm, dampness of the rare syndromes. Pulmonary fibrosis syndromes seen with the duration and age grouping. Acceptance of TCM syndromes of glucocorticoid therapy group did not receive glucocorticoid therapy group was no significant difference. With smoking history in patients with blood stasis syndrome is higher than the non-smoking patients with a history.